vs
Side-by-side financial comparison of Bio-Techne (TECH) and Wheels Up Experience Inc. (UP). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $183.8M, roughly 1.6× Wheels Up Experience Inc.). Bio-Techne runs the higher net margin — 12.8% vs -15.7%, a 28.6% gap on every dollar of revenue. On growth, Bio-Techne posted the faster year-over-year revenue change (-6.4% vs -10.2%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -3.4%).
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
Wheels Up is a provider of "on demand" private aviation in the United States and one of the largest private aviation companies in the world. It was founded in 2013 by Kenny Dichter, using a membership/on-demand business model. Wheels Up members can book private aircraft from the company fleet and third-party operators using a mobile application.
TECH vs UP — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $295.9M | $183.8M |
| Net Profit | $38.0M | $-28.9M |
| Gross Margin | 64.6% | 14.3% |
| Operating Margin | 18.4% | -0.9% |
| Net Margin | 12.8% | -15.7% |
| Revenue YoY | -6.4% | -10.2% |
| Net Profit YoY | 68.3% | 67.0% |
| EPS (diluted) | $0.24 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $295.9M | $183.8M | ||
| Q3 25 | — | $185.5M | ||
| Q2 25 | $317.0M | $189.6M | ||
| Q1 25 | $316.2M | $177.5M | ||
| Q4 24 | $297.0M | $204.8M | ||
| Q3 24 | $289.5M | $193.9M | ||
| Q2 24 | $306.1M | $196.3M | ||
| Q1 24 | $303.4M | $197.1M |
| Q4 25 | $38.0M | $-28.9M | ||
| Q3 25 | — | $-83.7M | ||
| Q2 25 | $-17.7M | $-82.3M | ||
| Q1 25 | $22.6M | $-99.3M | ||
| Q4 24 | $34.9M | $-87.5M | ||
| Q3 24 | $33.6M | $-57.7M | ||
| Q2 24 | $40.6M | $-97.0M | ||
| Q1 24 | $49.1M | $-97.4M |
| Q4 25 | 64.6% | 14.3% | ||
| Q3 25 | — | 6.8% | ||
| Q2 25 | 62.7% | 8.3% | ||
| Q1 25 | 67.9% | 10.8% | ||
| Q4 24 | 65.3% | 13.9% | ||
| Q3 24 | 63.2% | 13.9% | ||
| Q2 24 | 66.4% | 2.3% | ||
| Q1 24 | 67.4% | -0.6% |
| Q4 25 | 18.4% | -0.9% | ||
| Q3 25 | — | -33.1% | ||
| Q2 25 | -7.5% | -31.4% | ||
| Q1 25 | 12.2% | -45.5% | ||
| Q4 24 | 16.0% | -26.0% | ||
| Q3 24 | 13.8% | -21.6% | ||
| Q2 24 | 15.0% | -40.3% | ||
| Q1 24 | 22.1% | -42.9% |
| Q4 25 | 12.8% | -15.7% | ||
| Q3 25 | — | -45.1% | ||
| Q2 25 | -5.6% | -43.4% | ||
| Q1 25 | 7.1% | -55.9% | ||
| Q4 24 | 11.7% | -42.7% | ||
| Q3 24 | 11.6% | -29.8% | ||
| Q2 24 | 13.3% | -49.4% | ||
| Q1 24 | 16.2% | -49.4% |
| Q4 25 | $0.24 | $-0.04 | ||
| Q3 25 | — | $-0.12 | ||
| Q2 25 | $-0.11 | $-0.12 | ||
| Q1 25 | $0.14 | $-0.14 | ||
| Q4 24 | $0.22 | $-0.13 | ||
| Q3 24 | $0.21 | $-0.08 | ||
| Q2 24 | $0.26 | $-0.14 | ||
| Q1 24 | $0.31 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $172.9M | $133.9M |
| Total DebtLower is stronger | $260.0M | $671.3M |
| Stockholders' EquityBook value | $2.0B | $-392.1M |
| Total Assets | $2.5B | $968.8M |
| Debt / EquityLower = less leverage | 0.13× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $172.9M | $133.9M | ||
| Q3 25 | — | $125.3M | ||
| Q2 25 | $162.2M | $107.0M | ||
| Q1 25 | $140.7M | $171.8M | ||
| Q4 24 | $177.5M | $216.4M | ||
| Q3 24 | $187.5M | $115.9M | ||
| Q2 24 | $152.9M | $141.5M | ||
| Q1 24 | $145.3M | $180.9M |
| Q4 25 | $260.0M | $671.3M | ||
| Q3 25 | — | $766.5M | ||
| Q2 25 | $346.0M | $770.5M | ||
| Q1 25 | $330.0M | $765.8M | ||
| Q4 24 | $300.0M | $761.3M | ||
| Q3 24 | $300.0M | $596.9M | ||
| Q2 24 | $319.0M | $597.4M | ||
| Q1 24 | $389.0M | $603.2M |
| Q4 25 | $2.0B | $-392.1M | ||
| Q3 25 | — | $-374.5M | ||
| Q2 25 | $1.9B | $-347.8M | ||
| Q1 25 | $2.0B | $-288.1M | ||
| Q4 24 | $2.1B | $-202.1M | ||
| Q3 24 | $2.1B | $-117.7M | ||
| Q2 24 | $2.1B | $-72.2M | ||
| Q1 24 | $2.0B | $936.0K |
| Q4 25 | $2.5B | $968.8M | ||
| Q3 25 | — | $973.0M | ||
| Q2 25 | $2.6B | $1.0B | ||
| Q1 25 | $2.6B | $1.1B | ||
| Q4 24 | $2.7B | $1.2B | ||
| Q3 24 | $2.7B | $1.0B | ||
| Q2 24 | $2.7B | $1.1B | ||
| Q1 24 | $2.7B | $1.2B |
| Q4 25 | 0.13× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.19× | 644.43× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-18.4M |
| Free Cash FlowOCF − Capex | — | $-58.3M |
| FCF MarginFCF / Revenue | — | -31.7% |
| Capex IntensityCapex / Revenue | — | 21.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-259.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-18.4M | ||
| Q3 25 | — | $-37.1M | ||
| Q2 25 | $98.2M | $-62.9M | ||
| Q1 25 | $41.1M | $-47.9M | ||
| Q4 24 | $84.3M | $37.9M | ||
| Q3 24 | $63.9M | $-16.9M | ||
| Q2 24 | $75.5M | $-25.2M | ||
| Q1 24 | $81.0M | $-73.8M |
| Q4 25 | — | $-58.3M | ||
| Q3 25 | — | $-60.4M | ||
| Q2 25 | $93.3M | $-78.6M | ||
| Q1 25 | $31.0M | $-62.6M | ||
| Q4 24 | $77.5M | $-70.2M | ||
| Q3 24 | $54.7M | $-21.9M | ||
| Q2 24 | $57.5M | $-30.8M | ||
| Q1 24 | $64.5M | $-77.8M |
| Q4 25 | — | -31.7% | ||
| Q3 25 | — | -32.6% | ||
| Q2 25 | 29.4% | -41.5% | ||
| Q1 25 | 9.8% | -35.3% | ||
| Q4 24 | 26.1% | -34.3% | ||
| Q3 24 | 18.9% | -11.3% | ||
| Q2 24 | 18.8% | -15.7% | ||
| Q1 24 | 21.3% | -39.5% |
| Q4 25 | — | 21.7% | ||
| Q3 25 | — | 12.5% | ||
| Q2 25 | 1.5% | 8.3% | ||
| Q1 25 | 3.2% | 8.3% | ||
| Q4 24 | 2.3% | 52.8% | ||
| Q3 24 | 3.2% | 2.6% | ||
| Q2 24 | 5.9% | 2.9% | ||
| Q1 24 | 5.4% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.82× | — | ||
| Q4 24 | 2.42× | — | ||
| Q3 24 | 1.90× | — | ||
| Q2 24 | 1.86× | — | ||
| Q1 24 | 1.65× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
UP
Segment breakdown not available.
